{
    "url_original": "https://www.wsj.com/articles/purdue-pharmawarns-summer-bankruptcy-trial-could-be-delayed-11621540273?mod=business_featst_pos2",
    "url": "purdue-pharmawarns-summer-bankruptcy-trial-could-be-delayed-11621540273",
    "title": "Purdue Pharma Warns Summer Bankruptcy Trial Could Be Delayed",
    "sub_head": "A Purdue bankruptcy lawyer says open disputes over the companyâ€™s disclosures to creditors could delay an August trial over its chapter 11 plan",
    "time": "2021-05-20 15:51:00",
    "body": "Purdue Pharma LP said Thursday that a summer trial over its multibillion-dollar bankruptcy exit plan could be delayed if the OxyContin maker is unable to resolve open challenges to its proposal.<br />Stamford, Conn.-based Purdue is negotiating with different constituencies that have raised legal challenges to its disclosure statement, a document outlining its chapter 11 exit plan for creditors entitled to vote on it. A hearing on the disclosure statement in the U.S. Bankruptcy Court in White Plains, N.Y., has been twice postponed..."
}